Skip to main content
Ingredients/Amino acid/Glycylglycine

Glycylglycine.

Read pending.Glycylglycine is in the library; the clinical read is in the queue.

Research-backed amino acid with potential health benefits. In your body, it mostly just becomes glycine. It's used in labs to keep cell cultures happy, but as a supplement, it doesn't have a unique job.

500 to 1,500mgDaily amount11,076Studies read

Reviewed March 2026

GLAmino acid
GlycylglycineIngredientMD
Category
Amino acid

What Glycylglycine is, and what it does.

Does it work
It suits formulators who want glycine delivered in dipeptide form through the peptide transport route. Anyone whose interest is glycine itself gets the same building block from plain glycine.
How much to take
Don't. But if you must, dosages would theoretically track with glycine, around 3-5 grams. Again, just take glycine.
Time to feel it
Nobody has measured a timeline for this dipeptide in people. What it delivers is glycine, and glycine's effects are usually looked at over days to weeks.
The first dose
Nothing. It's not designed to have an acute effect. Your body will just digest it.
With regular use
No known long-term effects from supplementation because people don't take it long-term. Any effect would just be from the glycine it breaks down into.
How well tolerated
Considered well tolerated, as it's a peptide of a common amino acid. But the lack of supplement-specific studies means we're flying a bit blind.
How it feels
There is no sensation attached to it. What it contributes shows up in the background work glycine does: collagen, glutathione, bile acids and haem.
The overlooked benefit
It rides PEPT1, the small intestine's peptide transporter, so it comes in through a different door than free amino acids and does not queue behind them.

500 to 1,500mg a day is where Glycylglycine works.

How much to take a dayLimited data
500 to 1,500mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
3,000mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 5,000mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑01,500mg3,000mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Dipeptide research; biochemistry literature

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Read pending.

Glycylglycine is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.

  • glycine delivery through intestinal peptide transportNarrative review
  • glycine availability for glutathione synthesisNarrative review
  • buffering and nitrogen source in cell culture systemsIn vitro study
  • glycine as a structural residue in collagenNarrative review
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI11,076 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI11,076 studies readLabs test. IngredientMD verifies.

Questions people ask about Glycylglycine.

What is glycylglycine even used for?
Mostly in scientific labs as a buffering agent for experiments. It's not really meant for human supplements.
Are there any unique benefits?
None that have been shown in humans. For supplementation, all roads lead back to glycine.
Why do some products include it?
Usually for marketing or because it sounds technical in a proprietary blend. It's not a key player.
Is it found in food?
Yes, in tiny amounts wherever you find protein. But not in significant enough quantities to matter.
Pairs well with12 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Glycylglycine + Glycinethe dipeptide hydrolyses to two glycine residues

Intestinal and cytosolic peptidases split glycylglycine into two molecules of free glycine. Anything a formula gains from it is glycine delivered through the peptide carrier route.

Glycylglycine + L-glutamineEstablished pharmacology

Small peptides and free amino acids are absorbed by different routes: glycylglycine crosses the enterocyte on the PEPT1 proton-coupled peptide transporter, while glutamine uses amino acid carriers. Because the two routes do not compete, a peptide and a free amino acid can be delivered together without one crowding the other. This is transport physiology, not a measured combination effect.

Glycylglycine + L-cysteineEstablished pharmacology

Glycylglycine hydrolyses to two glycine molecules, and glycine is one of the three amino acids condensed into glutathione. Cysteine supplies the rate-limiting sulfur, glycine completes the tripeptide. Supplying both covers two of the three building blocks rather than one.

Glycylglycine + GlutathioneEstablished pharmacology

Glycine is the C-terminal residue of glutathione, added by glutathione synthetase to gamma-glutamylcysteine. A glycine-donating dipeptide feeds that final condensation step. Whether raising glycine availability changes tissue glutathione depends on which substrate is limiting in that tissue, and glycine is often not the limiting one.

Glycylglycine + CopperEstablished pharmacology

Glycylglycine forms well-characterised coordination complexes with copper through its amino nitrogen, peptide nitrogen and carboxylate, which is why it appears throughout the coordination chemistry literature as a copper-binding ligand. In a formulation the practical consequence is that a peptide and a copper salt in the same solution do not stay independent. The interaction is chemistry in the container, not a physiological claim.

Glycylglycine + L-lysineEstablished pharmacology

Lysine and glycine are both used in collagen synthesis, where glycine occupies every third position of the triple helix and lysine residues are hydroxylated to form crosslinks. A glycine-donating dipeptide and free lysine supply two different structural requirements. This describes the biosynthetic pathway rather than a measured effect on tissue.

Glycylglycine + L-prolineEstablished pharmacology

The collagen repeat is glycine-proline-hydroxyproline, so glycine and proline are the two most abundant residues in the molecule. Glycylglycine contributes glycine after peptidase cleavage. Amino acid supply is only one input to collagen formation, with vitamin C dependent hydroxylation being another.

Glycylglycine + Vitamin CEstablished pharmacology

Prolyl and lysyl hydroxylases require ascorbate to keep their iron centre reduced, and without that step the collagen helix does not stabilise. Supplying glycine without ascorbate leaves the hydroxylation step short. The cofactor relationship is settled biochemistry.

Glycylglycine + L-serineEstablished pharmacology

Serine hydroxymethyltransferase interconverts serine and glycine, transferring a one-carbon unit to tetrahydrofolate in the process. Glycine and serine therefore sit at the same node of one-carbon metabolism and their pools track each other. A glycine source shifts that equilibrium rather than acting on an isolated pathway.

The glycine cleavage system releases a one-carbon unit onto tetrahydrofolate, making glycine a folate-linked one-carbon donor. Folate availability determines whether that carbon is captured or lost. The two are parts of the same cycle rather than separate additions.

Glycylglycine + Creatine monohydrateEstablished pharmacology

Endogenous creatine is built from glycine, arginine and a methyl group from S-adenosylmethionine, with glycine providing the backbone. Supplying creatine directly reduces the demand on that pathway, while supplying glycine feeds it. Which route matters depends on whether creatine is coming in from the diet.

Glycylglycine + ZincEstablished pharmacology

Glycine and glycine-containing peptides coordinate zinc, which is the basis of zinc bisglycinate as a formulation approach. A dipeptide in the same product will participate in that equilibrium. The direction depends on the relative binding constants of everything else in the mix.

Who should be cautious

Nothing specific on file for Glycylglycine. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Glycylglycine actually does.

Established

Glycylglycine is the simplest dipeptide, two glycine residues joined by a single peptide bond, with a free amino terminus and a free carboxyl terminus.

Established

Intestinal brush border and cytosolic peptidases hydrolyse it to two molecules of glycine, so its systemic contribution is a glycine contribution.

Established

Absorption of the intact dipeptide is handled by PEPT1, the proton-coupled oligopeptide transporter of the small intestine, which is a separate route from the carriers that move free amino acids.

Established

Glycine is a substrate for glutathione synthesis, creatine synthesis, haem synthesis via delta-aminolevulinic acid, bile acid conjugation, and the collagen triple helix, where it occupies every third position.

Made in a lab, 6 steps on record

Where Glycylglycine comes from.

It is built in a reactor by joining two glycine molecules together. Chemists block one end of each so the reaction makes exactly one link rather than a long chain, then strip the blocking groups off and crystallise the result out of water. The main quality question is how much loose glycine and how many longer chains are left behind.

Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.

Starts as
Glycine

Two molecules of glycine are the starting material. Commercial glycine is itself produced by chemical synthesis, most commonly from chloroacetic acid and ammonia, or by fermentation routes.

Converted by
Amino and carboxyl protection

One glycine has its amino group blocked and the other has its carboxyl group activated, so that the coupling forms one specific peptide bond rather than a mixed polymer.

Converted by
Peptide bond formation

The activated carboxyl and the free amine are coupled, releasing water and forming the single amide bond that defines the dipeptide. Alternative routes go through glycine anhydride (2,5-diketopiperazine), which is hydrolysed under controlled conditions to open the ring into glycylglycine.

Purified by
Deprotection, crystallisation and recrystallisation

Protecting groups are removed and the product is crystallised from water or aqueous alcohol, then recrystallised to separate it from unreacted glycine, the cyclic anhydride and higher oligomers.

Standardised to
Assay and residue testing

Identity and purity are confirmed by chromatography and melting point, with free glycine content, water and residual solvent measured against a specification.

Ends up as
Crystalline powder

Delivered as a dry crystalline powder for capsules, buffered solutions or laboratory use.

The forms it comes in.

GlycylglycineThe zwitterionic free dipeptide, a white crystalline solid soluble in water.Fits Powder and capsule formats where a defined dipeptide rather than free glycine is wanted.Trade-off Costs more than free glycine per gram of glycine delivered, and hydrolyses to glycine regardless.
Glycylglycine HClThe hydrochloride salt, formed by protonating the amino terminus, which lowers the pH of a solution and raises solubility.Fits Liquid preparations where an acidic pH is intended or where the free base dissolves too slowly.Trade-off Contributes chloride and acidity, so the finished pH has to be adjusted for anything not meant to be acidic.Formulation aid
Glycylglycine sodium saltThe sodium salt of the carboxylate, used where a buffered near-neutral solution is the goal.Fits Buffered liquids and reconstitution systems.Trade-off Adds sodium and, like any buffer component, interacts with the metal ions present in the same solution.Formulation aid
What the strongest studies found

The essence, in one line each.

  1. A systematic review of metabolomic studies lists glycylglycine among the circulating metabolites reported as differing between compared groups; this is a marker association within a broader panel, not evidence that supplementing the dipeptide changes anything.Systematic review. Yao et al., 2025 (Frontiers in Psychiatry). PMID 40225847
  2. A meta-analysis of metabolomic data names glycylglycine among metabolites distinguishing groups with differing bone density; an association between a measured metabolite and a state, not a demonstrated effect of intake.Meta-analysis. Wang et al., 2023 (Nutrients). PMID 38068753

These are the studies our verdict leans on, chosen from the 2 we read for Glycylglycine. The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.